My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Bayer to acquire Monsanto in all cash transaction

Bayer to acquire Monsanto in all cash transaction

Sep 14,2016

Monsanto India announced that Bayer and Monsanto signed definitive agreement under which Bayer will acquire Monsanto for USD 128 per share in an all cash transaction.

Powered by Capital Market - Live News

Selan Explorations Technology to hold AGM
Jul 05,2017

Selan Explorations Technology announced that the th Annual General Meeting(AGM) of the company on 10 August 2017.

Powered by Capital Market - Live News

IDFC Bank to hold board meeting
Jul 05,2017

IDFC Bank will hold a meeting of the Board of Directors of the Company on 27 July 2017 to discuss and approve, among other items, the Unaudited Financial Results (subjected to Limited Review by Auditors) for the quarter ended June 30, 2017.

Powered by Capital Market - Live News

Hindalco Industries allots 84,694 equity shares
Jul 05,2017

Hindalco Industries has allotted 84,694 equity shares of face value of Re. 1/- each to the optionees as detailed in the resolution , pursuant to the exercise of the options granted to the employee under the Companys Employee Stock Option Scheme.

Powered by Capital Market - Live News

Timken India, ABC Bearings in demand
Jul 05,2017

The announcement was made after market hours yesterday, 4 July 2017.

Timken India (up 7.40% at Rs 726) and ABC Bearings (up 20% at Rs 285.70).

Meanwhile, the S&P BSE Sensex was up 5.93 points, or 0.02% at 31,215.72.

As per the proposed scheme, Timken India will issue 5 equity shares for every 8 equity shares held in ABC Bearings. The transaction is expected to close in the quarter ended 31 March 2018, subject to the receipt of all approvals.

The scheme is subject to the approval of the shareholders and creditors of ABC Bearings, approval of the regulatory authorities and the sanction of the National Company Law Tribunal.

The amalgamation will help both the firms to achieve larger product portfolio, access new domestic and export markets, increase market share, economies of scale, efficiency, and other related economies. The scheme intends to merge the operations of ABC Bearings with that of Timken India to fulfill this objective.

Net profit of ABC Bearings rose 53% to Rs 4.88 crore on 0.5% decline in net sales to Rs 52.41 crore in Q4 March 2017 over Q4 March 2016.

ABC Bearings is engaged in the business of engineering, product design, manufacturing, distribution and sale of bearings.

Net profit of Timken India declined 3.5% to Rs 25.71 crore on 4.4% decline in net sales to Rs 270.44 crore in Q4 March 2017 over Q4 March 2016.

Timken India is engaged in the business of engineering and manufacturing bearings and mechanical power transmission components including gear drives, couplings, belts and chain.

Powered by Capital Market - Live News

Reliance Industrial Infrastructure to hold AGM
Jul 05,2017

Reliance Industrial Infrastructure announced that the 29th Annual General Meeting (AGM) of the company will be held on 28 July 2017.

Powered by Capital Market - Live News

Lupin launches generic Vigamox Ophthalmic solution
Jul 05,2017

Lupin announced the launch of its Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5% (base) having received an approval from the United States Food and Drug Administration earlier. It is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the organism.

Lupins Moxifloxacin Hydrochloride Ophthalmic solution USP, 0.5% (base), is an AT1 rated generic equivalent of Novartis Pharms Corp.s Vigamox Opthalmic solution.

Powered by Capital Market - Live News

Cadila Healthcare gains on starting phase II trial on anemia drug
Jul 05,2017

The announcement was made during trading hours today, 5 July 2017.

Meanwhile, the S&P BSE Sensex was up 30.36 points, or 0.10% to 31,240.15.

On the BSE, 35,000 shares were traded in the counter so far, compared with average daily volumes of 1.54 lakh shares in the past one quarter. The stock had hit a high of Rs 521.05 and a low of Rs 508.35 so far during the day. The stock hit a record high of Rs 558 on 12 June 2017. The stock hit a 52-week low of Rs 328.90 on 5 July 2016.

The stock had outperformed the market over the past one month till 4 July 2017, rising 4.93% compared with 0.32% decline in the Sensex. The scrip had also outperformed the market in past one quarter, rising 14.73% as against Sensexs 4.12% rise. The scrip had also outperformed the market in past one year, rising 53.80% as against Sensexs 14.88% rise.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Cadila Healthcare announced the initiation of a phase Il trial investigating ZYAN1, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), as a treatment for anemia associated with chronic kidney disease (CKD).

ZYAN1 is an oral small molecule that has been designed to inhibit hypoxia-inducible factor prolyl hydroxylase, and thereby increase the natural production of hemoglobin and Red Blood Cell Count (RBC) in anemic patients. ZYAN1 has been shown to improve iron mobilization and has the potential to reduce or eliminate the need for iron supplementation.

Two phase I trials of ZYAN1 have been concluded in Australia and India, and results were recently published in Clinical Pharmacokinetics. ZYAN1 was safe and well-tolerated in healthy volunteers following single escalating oral doses (10n++300 mg) and multiple escalating oral doses (100n++300 mg). The measurement of serum erythropoietin (EPO) levels in healthy volunteers confirmed the pharmacodynamic effect as EPO increased with increasing ZYAN1 doses in relation to placebo.

Anemia is a global public health problem affecting both developing and developed countries. Anemia commonly arises in kidney disease patients, because the kidneys no longer produce sufficient amounts of erythropoietin, a hormone which stimulates red blood cell production. Symptoms of anemia may include fatigue, skin pallor, shortness of breath, light-headedness, dizziness or a fast heartbeat. The Global ESA Market was estimated at $7 billion worldwide.

Cadila Healthcares consolidated net profit fell 32.2% to Rs 385.5 crore on 6.5% rise in net sales to Rs 2417.50 crore in Q4 March 2017 over Q4 March 2016.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

Motilal Oswal Financial Services to hold AGM
Jul 05,2017

Motilal Oswal Financial Services announced that the th Annual General Meeting(AGM) of the company on 27 July 2017.

Powered by Capital Market - Live News

Bhansali Engineering advances after expansion plans
Jul 05,2017

The announcement was made after market hours yesterday, 4 July 2017.

Meanwhile, the S&P BSE Sensex was up 23.49 points, or 0.08% to 31,233.28. The S&P BSE Smjall-Cap index was up 131.84 points, or 0.85% to 15,698.77.

On BSE, 7.80 lakh shares were traded in the counter so far as against an average daily volume of 11.23 lakh shares in the past one quarter. The stock hit a high of Rs 70.55 and a low of Rs 68.05 so far during the day. The stock hit a record high of Rs 70.85 yesterday, 4 July 2017. The stock hit a 52-week low of Rs 18.95 on 29 September 2016.

The stock had outperformed the market over the past one month till 4 July 2017, rising 65% compared with 0.32% decline in the Sensex. The scrip had also outperformed the market in past one quarter, surging 90.3% as against Sensexs 4.12% rise. The scrip had outperformed the market in past one year, jumping 231.62% as against Sensexs 14.88% rise.

The small-cap company has equity capital of Rs 16.59 crore. Face value per share is Re 1.

Bhansali Engineering Polymers scheduled a board meeting on 14 July 2017 to consider expansion project of company for increasing ABS production capacity from existing 80 kilo tonnes per annum (KTPA) to 137 KTPA inter alia other businesses.

Bhansali Engineering Polymers net profit surged 1908% to Rs 15.06 crore on 23.56% rise in net sales to Rs 192.73 crore in Q4 March 2017 over Q4 March 2016.

Bhansali Engineering Polymers is a vertically integrated petrochemical company that manufactures ABS which acts as a raw material for leading companies dealing in automobiles, home appliances, telecommunications, luggage, bus body and various other applications.

Powered by Capital Market - Live News

PMGSY registers significant success in the first quarter of 2016-17
Jul 05,2017

Pradhan Mantri Gram Sadak Yojana (PMGSY) is being implemented across the country, particularly, in States having historical deficit of rural roads (Assam, West Bengal, Odisha, Bihar, Jharkhand, Madhya Pradesh, Chhattisgarh, Rajasthan, Himachal Pradesh, J&K and Utttrakhand ) as never before. The pace of construction of PMGSY roads reached a 7 year high of 130 kms per day in 2016-17 as against an average of 73 kms during the period 2011 to 2014. In the present financial year 2017-18, the target is to construct 57,000 kms of PMGSY roads, at an average per day rate of 156 kms and to provide connectivity to 16,600 eligible habitations.

In the first quarter of the present financial year 2017-18 (April-June, 2017), a total of 10,556 kms of PMGSY roads have been constructed, clocking an average of 117.28 kms per day. This compares very favorably to the first quarter of 2016-17 (April-June, 2016), when a total length of 8,756 kms was constructed at an average of 97.29 kms per day. The progress in terms of length constructed in the present financial year is 18.51% of the total annual target. The present rate of construction would further accelerate from October, 2017 to March, 2018. Hence, there is every reason to believe that the annual targets will be met with a strong probability of achievement exceeding the targets.

Against an annual target of providing connectivity to 16,600 eligible habitations, in the first quarter of the financial year 2017-18, 2,543 habitations have been provided connectivity, which is 15.31% of the annual target.

PMGSY aims to connect 1,78,184 eligible habitations across the country out of which projects relating to 1,61,576 habitations have already been sanctioned (90.67% of the eligible habitations) and 1,29,004 habitations have been connected till June, 2017 (72.39% of eligible habitations and 79.84% of sanctioned habitations), by constructing a total of 5,12,031 kms of roads.

PMGSY has also focused on use of non-conventional construction materials (waste plastic, cold mix, fly ash, jute and coir geo-textiles, iron and copper slag, cell filled concrete, paneled cement concrete etc.) and n++Green Technologiesn++ in PMGSY roads. The target for use of such materials and technologies during 2017-18 is 10,082 kms. Against this target, in the first quarter of the financial year till June, 2018, 1,235.22 kms have been constructed. The States which are doing particularly well in this field are Rajasthan (381 kms), Punjab (181 kms), Odisha (131.38 kms), Madhya Pradesh (116.07 kms) and Tamil Nadu (102 kms).

Powered by Capital Market - Live News

Jubilant Life Sciences firms up after broker initiates coverage
Jul 05,2017

Meanwhile, the S&P BSE Sensex was up 31.29 points, or 0.10% to 31,241.08.

On the BSE, 50,000 shares were traded in the counter so far, compared with average daily volumes of 81,924 shares in the past one quarter. The stock had hit a high of Rs 727.95 and a low of Rs 710 so far during the day. The stock hit a record high of Rs 879.10 on 12 April 2017. The stock hit a 52-week low of Rs 298.05 on 18 July 2016.

The stock had underperformed the market over the past one month till 4 July 2017, falling 5.31% compared with 0.32% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 17.13% as against Sensexs 4.12% rise. The scrip had, however, outperformed the market in past one year, rising 117.95% as against Sensexs 14.88% rise.

The large-cap company has equity capital of Rs 15.93 crore. Face value per share is Re 1.

The domestic brokerage reportedly expects strong growth in pharma and life science ingredients segments going ahead.

Jubilant Life Sciences consolidated net profit spurted 1272.3% to Rs 149.03 crore on 7% growth in net sales to Rs 1565.79 crore in Q4 March 2017 over Q4 March 2016.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery solutions.

Powered by Capital Market - Live News

Relaxo Footwears drops after recent sharp rally
Jul 05,2017

Meanwhile, the S&P BSE Sensex was up 43.16 points, or 0.14% at 31,252.95. The S&P BSE Mid-Cap index was up 92.94 points, or 0.63% at 14,851.78.

High volumes were witnessed on the counter. On the BSE, 14,000 shares were traded on the counter so far as against the average daily volumes of 3,258 shares in the past one quarter. The stock had hit a high of Rs 534.90 and a low of Rs 520.40 so far during the day. The stock had hit a 52-week high of Rs 554.90 on 4 July 2017 and a 52-week low of Rs 373 on 9 November 2016.

The stock had outperformed the market over the past one month till 4 July 2017, advancing 15.34% compared with the Sensexs 0.2% fall. The scrip had also outperformed the market over the past one quarter advancing 9.03% as against the Sensexs 4.34% rise. The scrip had, however, underperformed the market over the past one year advancing 11.63% as against the Sensexs 14.41% rise.

The mid-cap company has equity capital of Rs 12.01 crore. Face value per share is Rs 1.

Shares of Relaxo Footwears had rallied 13.43% in the preceding one trading session to settle at Rs 543.25 yesterday, 4 July 2017, from its close of Rs 478.95 on 3 July 2017.

Relaxo Footwears net profit rose 4.5% to Rs 34.30 crore on 2.8% increase in net sales to Rs 498.29 crore in Q4 March 2017 over Q4 March 2016.

Relaxo Footwears is a footwear maker.

Powered by Capital Market - Live News

Trade-Wings to hold AGM
Jul 05,2017

Trade-Wings announced that the 67th Annual General Meeting(AGM) of the company on 27 July 2017.

Powered by Capital Market - Live News

Voltaire Leasing & Finance to hold board meeting
Jul 05,2017

Voltaire Leasing & Finance will hold a meeting of the Board of Directors of the Company on 5 July 2017.

Powered by Capital Market - Live News

Mahindra & Mahindra Financial Services to raise funds aggregating Rs 2000 crore
Jul 05,2017

Mahindra & Mahindra Financial Services plans to raise Rs 250 crore through unsecured subordinated redeemable NCDs via public issue with option to retain oversubscription upto Rs 1750 crore aggregating Rs 2000 crore. The issue opens on 10 July 2017 and closed on 28 July 2017.

Powered by Capital Market - Live News